Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Reversal of Acute β-Blocker Induced Bronchoconstriction
NCT01070225Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Mar 2010
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma comparing Hydrocortisone and Propranolol with Placebo and Propranolol (2 arms). Primary endpoint: Airway reversibility and recovery with systemic corticosteroids and nebulised bronchodilators following histamine challenge at 3 weeks. Started Mar 2010; status: completed.
02
Drugs
hydrocortisone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01070225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01070225.